The global CAR T-cell therapy market is experiencing significant growth, fueled by increasing adoption of this innovative therapy for a range of malignancies. Key drivers shaping the market include increasing prevalence of cancer, advancements in science, and supportive guidelines. The market is characterized by a fragmented landscape with numerou